Appendix 3B - Proposed issue of securities Announcement Summary Entity name FIREBRICK PHARMA LIMITED Announcement Type New announcement Date of this announcement 12/11/2026 The Proposed issue is: A placement or other type of issue Total number of +securities proposed to be issued for a placement or...
Proposed issue of securities - FRE
Filed with ASX · · 5 pages · English
Summary by 6ix AI
Firebrick Pharma Limited has announced a proposed issue of securities, specifically unlisted options, as part of a placement initiative. The company plans to issue a significant number of these options, which will expire five years from the date of issue. The main purpose of this issuance is to provide a retention incentive for the Directors as part of their remuneration package. The proposed issue date is set for mid-November of the following year.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Firebrick Pharma Limited on 6ix
Earlier from Firebrick Pharma
- Results of Annual General Meeting
- September 2026 Quarterly Activity Report & Appendix 4C
- New Product - Nasodine Sinus Rinse
- Change in substantial holding - Pharma Nutria
- Cleansing Notice
Later from Firebrick Pharma
- Change of Director's Interest Notice - Al Moghaddam
- Change of Director's Interest Notice - Peter Molloy
- Change of Director's Interest Notice - Rick Legleiter
- Change of Director's Interest Notice - Stephen Goodall
- Notification regarding unquoted securities - FRE
Follow Firebrick Pharma into a list and get an email when it puts out news.
Follow Firebrick Pharma